Neuroblastoma (NB) is the most common extracranial solid tumor that originates from multipotent neural crest cells. NB cell populations that express embryonic stem cell-associated genes have been identified and shown to retain a multipotent phenotype. However, whether somatic reprogramming of NB cells can produce similar stem-cell like populations is unknown. Here, we sought to reprogram NB cell lines using an integration-free Sendai virus vector system. N euroblastomas (NBs) are solid tumors that occur during childhood. These tumors arise in the peripheral sympathetic nervous system, particularly in the adrenal medulla and sympathetic ganglia, manifesting as thoracic, paraspinal, or abdominal tumors with metastasis to other parts of the body.
Neuroblastoma (NB) is the most common extracranial solid tumor that originates from multipotent neural crest cells. NB cell populations that express embryonic stem cell-associated genes have been identified and shown to retain a multipotent phenotype. However, whether somatic reprogramming of NB cells can produce similar stem-cell like populations is unknown. Here, we sought to reprogram NB cell lines using an integration-free Sendai virus vector system. N euroblastomas (NBs) are solid tumors that occur during childhood. These tumors arise in the peripheral sympathetic nervous system, particularly in the adrenal medulla and sympathetic ganglia, manifesting as thoracic, paraspinal, or abdominal tumors with metastasis to other parts of the body. (1) NBs originate from multipotent neural crest stem cells; these particular stem cells give rise to diverse cell lineages, including Schwann cells, melanocytes, craniofacial cartilage, peripheral neurons, and glia. (2) Some human NB cell lines partially retain a multipotent phenotype and can differentiate into several cell types. (3) (4) (5) (6) Intermediate type (I-type) NB cells possess morphological and biochemical properties of both neuroblastic and substrate-adherent NB cells, and differentiate into either type upon retinoic acid or BrdU treatment, respectively. (3) (4) (5) (6) I-type NB cells show increased tumorigenic potential compared with neuroblastic or substrate-adherent NB cells, (3) suggesting that epigenetic changes in NBs contribute to aggressiveness. Indeed, recent studies have revealed that abnormal epigenetic regulation is one of the driving forces underlying NB tumorigenesis. (7) (8) (9) (10) Somatic cell reprogramming by forced expression of defined transcription factors has paved the way to generate patientspecific stem cell sources. (11) These induced pluripotent stem cells (iPSCs) possess key features of embryonic stem cells (ESCs), including self-renewal and pluripotency. Several cancer cell lines have been reprogrammed via ectopic expression of defined transcription factors. (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) Reprogrammed sarcoma and glioblastoma cells retain the same genomic aberrations as parental cells and can differentiate into multiple lineages. (20, 21) While reprogramming of cancer cells is a useful technique for investigating how epigenetic changes affect the plasticity of tumor cells, this technique has not been reported in NB cells to date. Here, we attempted to reprogram human NB cells to promote plasticity using a Sendai virus (SeV) vector encoding Yamanaka factors (OCT4, SOX2, KLF4, and c-MYC) for transgene-free reprogramming of iPSCs. (23, 24) We used this SeV vector system to reprogram NB cells to minimize the deleterious effects on the host genome and prevent subsequent gain of artificial tumorigenic activities.
Materials and methods
SeV-mediated expressions of reprogramming factors in NB cells. SeV vectors encoding the four Yamanaka factors (OCT4, SOX2, KLF4, and c-MYC) were obtained from DNAVEC Corporation (Ibaraki, Japan) and used according to the manufacturer's instructions. (23) We plated 5 9 10 5 cells and incubated them overnight in the appropriate medium. The next day, cells were transduced with SeV vectors at a multiplicity of infection of three and maintained at 37°C in 5% CO 2 . At 24 h post-transduction, the virus-containing medium was removed and fresh medium was added every subsequent day. At 6 days post-transduction, cells were dissociated with Accutase (Stemcell Technologies, Vancouver, BC, Canada), counted, and re-plated onto mouse embryonic fibroblasts (MEFs). The next day, the media was switched to primate ES cell medium (ReproCELL) containing 4 ng ⁄ mL basic fibroblast growth factor (bFGF, ReproCell, Yokohama, Japan) and 10 lM ROCK inhibitor and incubated at 37°C in 3% CO 2 . Medium was changed daily.
Endothelial tube formation assay. In vitro capillary-like tube formation was studied on Matrigel-coated wells in specific culture medium (Tube Formation Kit; Trevigen, Gaithersburg, MD, USA). NB cells were seeded onto matrigel-coated wells in Endothelial Basal Medium without serum in the presence of vascular endothelial growth factor (VEGF; 5-15 ng ⁄ mL) and bFGF (20-50 ng ⁄ mL). Normal human umbilical vein endothelial cells (HUVECs) maintained in Endothelial Cell Growth Medium 2 (PromoCell GmbH, Heidelberg, Germany) served as a positive control for tube formation. Tube-like structure formation on matrigel was observed over a 6-48 h period and results were recorded. To evaluate cell differentiation, NB cells were incubated in EndoGRO-MV-VEGF complete media kit (Millipore) with VEGF (5 ng ⁄ mL) on gelatincoated plates. The medium was changed every other day for 1 week. Cells were then stained by immunofluorescence for CD31.
More detailed descriptions of the Material & Methods are provided in Suppl. Data S1.
Results
SeV-mediated expression of reprogramming factors in NB cells.
High expression levels of pluripotency-associated genes in parental cells are related to the efficiency of iPSC generation. (25) To identify suitable candidate cell lines for reprogramming, we analyzed the expression levels of pluripotency-associated genes-including NANOG, OCT4, SOX2, and KLF4-in 24 NB cell lines (Suppl. Fig. S1 ). We selected the NB cell lines SK-N-AS and SK-N-DZ for reprogramming based on their high expression of two (NANOG and KLF4) and three (NANOG, OCT4, and KLF4) pluripotency-associated genes, respectively (Suppl. Fig. S1 ). We also selected the two I-type NB cell lines SH-IN and BE(2)-C, as they exhibit stem celllike characteristics and express pluripotency-associated genes at high levels (Suppl. Figs S1B and S2).
In contrast to BJ cells, all four NB cell lines proliferated rapidly in serum-free ES medium, with MEF cells dying within a week. Therefore, we prepared new MEF feeder cells weekly. SH-IN cells gave rise to iPSC-like colonies (SH-IN 4F) approximately 6 weeks after transduction ( Fig. 1 and Suppl. Fig. S3) . Each colony was then transferred into two 96-well plates using a transfer pipet. One plate was used for AP staining and the other for passage. We selected 12 clones based on strong AP activity and cultured them for 2 months to eliminate the SeV transgenes. We were unable to detect any colonies from the SK-N-AS, BE(2)-C, or SK-N-DZ cell lines up to 7 weeks after induction. The SH-IN 4F clones could be successfully expanded and maintained in culture for at least 40 passages. To determine the presence of transgenes or a viral backbone, we examined clones using reverse transcription-polymerase chain reaction (RT-PCR). We selected three clones (2, 7, and 11) based on eliminated transgenes (Fig. 1b) . SH-IN 4F cells were positive for AP staining (Fig. 1c) . Some cells at the periphery of SH-IN 4F colonies lost AP activity 3 days after passage. Therefore, SH-IN 4F cells were passaged every 3 days.
Characterization of SH-IN 4F cells. Immunocytochemistry analysis showed that SH-IN 4F cells expressed ESC-related core transcription factors, including NANOG, OCT4, and SOX2 in a manner similar to neonatal human foreskin fibroblast BJ-iPSCs and human dermal fibroblast-derived iPSCs (201B7; Fig. 2a and Suppl. Fig. S4 ). Expression of ESC-specific surface markers, including stage specific embryonic antigen-4 (SSEA-4), tumor related antigen-1 (TRA-1-60), and tumor related antigen-1-81 (TRA-1-81), was also apparent in SH-IN 4F cells (Fig. 2a) . qPCR analysis revealed that expression of endogenous OCT4, SOX2, and KLF4 was induced in SH-IN 4F cells at levels comparable with those in iPSCs (Suppl. Fig. S5 ). NANOG, c-MYC, LIN28, and hTERT were highly expressed in SH-IN 4F cells compared with iPSCs, whereas CHD1, DNMT3B, and TDGF1 were not induced (Suppl. Fig. S5 ).
Reprogramming of somatic cells is accompanied by demethylation of the promoter regions of key pluripotency-associated transcription factors. (11) We used bisulfite genomic sequencing to determine the degree of CpG methylation in the OCT4 and NANOG promoters of SH-IN and SH-IN 4F cells (Fig. 2b,c) . In contrast with 201B7 and BJ-iPSCs, (23) methylation of the OCT4 promoter in SH-IN and SH-IN 4F cells remained high even after reprogramming (Fig. 2b) . Meanwhile, methylation of the NANOG promoter was low in both SH-IN and SH-IN 4F cells (Fig. 2c) .
Analysis (Fig. 4a) . We observed upregulation of ectodermal (PAX6 and SOX1), mesodermal (HAND1 and FOXF1), and endodermal (AFP and GATA6) markers in SH-IN 4F cells, similar to EBs from iPSCs ( Fig. 4b and Suppl. Fig. S6 ). We also confirmed the expression of three germ layer-specific markers by immunocytochemical analyses (Fig. 4c) . However, in contrast with iPSCs, endogenous expression levels of pluripotency-associated genes (OCT4, SOX2, c-MYC, and KLF4) were minimally downregulated during EB formation (Suppl. Fig. S7 ). Furthermore, GATA6 was localized to the cytoplasm but not the nucleus (Fig. 4c) . We injected SH-IN 4F or parental SH-IN into the testes of NOD-SCID mice and found that SH-IN 4F formed NBs rather than teratomas (Suppl. Fig. S8 ). These results suggest that SH-IN 4F cells are partially reprogrammed cells, maintaining endogenous expression of reprogramming factors at high levels.
Spontaneous differentiation of SH-IN 4F cells. Cells in the center of the SH-IN 4F colonies showed similar morphology to iPSCs. However, at more than 3 days after passage, some cells at the periphery of the colonies resembled parental SH-IN cells. These cells migrated from colonies and were dispersed over the culture surface and formed monolayers (Suppl. Figs S3A and S9A ). Previous reports suggest that reprogrammed cells preserve the memory of their origin and demonstrate a tendency toward spontaneous differentiation. (26) We therefore examined whether cells at the periphery of the SH-IN 4F colonies had lost expression of specific markers of pluripotency (TRA-1-81 and OCT4) and recovered expression of the neuronal specific maker (bIII tubulin; Suppl. Fig. S9 ). The centers of SH-IN 4F colonies exhibited high levels of AP activity and expressed TRA-1-81 (Suppl. Fig. S9A,B) . Meanwhile, cells at the periphery were negative for pluripotency markers (Suppl. Fig. S9A,B) . The 201B7-iPSCs expressed OCT4 at high levels in the undifferentiated state (Suppl. Fig. S9C ). However, expression of OCT4 was repressed in EBs from 201B7-iPS cells, and this was accompanied by the induction of bIII tubulin (Suppl. Fig. S9C ). In contrast, SH-IN parental cells exhibited homogeneous staining of bIII tubulin and lower expression of OCT4 (Suppl. Fig. S9D ). Most cells in SH-IN 4F colonies were OCT4-positive, with some of the peripheral cells staining positive for bIII tubulin (Suppl. Fig. S9D ). At more than 3 days after passage, OCT4 localized to both the nucleus and cytoplasm of SH-IN 4F cells in colonies (Suppl. Fig. S9D ). However, similar to human iPSCs (Suppl. Fig. S4 ), OCT4 mainly localized to the nuclei of SH-IN 4F cells when cells were passaged every 3 days (Fig. 2a) . Therefore, spontaneous differentiation of SH-IN 4F cells changed the subcellular localization of OCT4.
SH-IN 4F cells differentiate into vascular endothelial-like cells.
OCT4 is expressed in a subpopulation of NB cells, (27) and OCT4-positive NB cells serve as progenitors of tumor-derived endothelial cells. (28) We therefore examined the ability of SH-IN 4F cells to form vascular endothelial-like structures. Normal HUVECs were used as a positive control. SH-IN 4F cells formed a network of cells (Fig. 5a, center panel) , although the tube networks were thick and less organized compared with HUVECs (Fig. 5a, left panel) . Parental SH-IN cells gathered together under the differentiating medium without forming tube-like structures (Fig. 5a, right panel) . SH-IN 4F cells expressed the endothelial-specific marker CD31 (Fig. 5b ) and the proportion of CD31 + cells was significantly increased compared with parental SH-IN cells (Fig. 5c) .
We next performed immunohistochemical staining for human CD31 (Suppl. Fig. S10A,B) and the immature endothelial cell maker prostate-specific membrane antigen (28) (PSMA; Suppl. Fig. S10C,D) , using tumor xenografts. Some spindle-shape cells were positive for human PSMA, but no specific signals for human CD31 were detected in the xenograft tumors, although western blots for CD31 suggested the induced expression of CD31 in SH-IN 4F tumors (Suppl. Fig. S10E (Fig. 6) . We then investigated the molecular mechanisms underlying chemoresistance in SH-IN 4F cells by measuring the expression of several genes known to promote chemoresistance in NB. Increased expression of CD133, (29) ALDH1A1, (30) ARID3B, (10, 31) and NCYM (32) was detected in SH-IN 4F cells, while MYCN expression did not change (Suppl. Fig. S11 ). In contrast, reprogramming of BJ cells induced expression of MYCN, NCYM, and ARID3B (Suppl. Fig. S11C ).
Discussion
We expressed reprogramming factors in NB cells using a non-integrating SeV vector. Similar to human iPSCs, SH-IN 4F cells expressed pluripotency-associated genes following reprogramming. Furthermore, markers of all three embryonic germ layers were induced during EB formation. Some cells at the periphery of SH-IN 4F colonies spontaneously differentiated into neuronal cells, with cells positive for both OCT4 and bIII tubulin detected. OCT4-positive NB cells possess the ability to differentiate into tumor cell-derived vascular-endothelial cells, (28) and OCT4 is highly expressed in stem-like cells-such as side-population cells. (27) Consistent with these reports, SH-IN 4F cells formed vascular endothelial-like structures in differentiating medium, and expressed the endothelial marker CD31. Taken together these findings indicate that SeV-mediated expression of reprogramming factors increased the plasticity of SH-IN cells in vitro.
Reprogramming of SH-IN cells was not sufficient to allow endothelial differentiation in vivo, though human CD31 expression was slightly induced. Given that the percentage of cells positive for PSMA in parental SH-IN cells was relatively low compared with other NB cell lines, (28) endothelial differentiation of SH-IN cells in vivo may also be rare. Further experiments are required to clarify the molecular mechanisms underlining the barriers to endothelial differentiation of SH-IN cells in vivo.
Demethylation of the OCT4 promoter was limited in SH-IN 4F cells, although the expression level of OCT4 mRNA was comparable with that in iPSCs. Additionally, there was no induction of CHD1, DMNT3B, or TDGF1 expression in SH-IN 4F cells, and endogenous expression of reprogramming factors was minimally downregulated during EB formation. GATA6 localized to the cytoplasm in SH-IN 4F-derived EBs, and SH-IN 4F cells formed NBs-but not teratomas-in vivo. These results suggest that SH-IN 4F cells, while de-differentiated, were not fully reprogrammed.
Similar to SH-IN 4F cells, reprogrammed A549 human lung cancer cells highly expressed OCT4 with limited demethylation of the OCT4 promoter. (33) Reprogrammed A549 cells generated invasive tumors compared with the parental cells, but the tumors were not typical teratomas, suggesting that the partial de-differentiation induced by reprogramming contributes to tumor aggressiveness. Using in vivo reprogramming mouse models, Ohnishi et al. recently reported that premature termination of reprogramming resulted in development of childhood blastomas-but not teratomas. Meanwhile long-term in vivo activation of Yamanaka factors facilitated teratoma formation. (34) Ikegaki et al. (9) revealed that treatment of NB cell lines with epigenetic modifiers in sphere-forming cultures enabled re-activation of reprogramming factors and induced development of poorly differentiated stem cell-like NB cells. Injection of these induced cancer stem cells into mice resulted in the formation of NBs-but not teratomas-supporting the notion that de-differentiation by partial reprogramming promotes tumor aggressiveness.
Our findings reveal that partial reprogramming of SH-IN cells facilitates CDDP resistance and enhanced differentiation into endothelial-like cells, resulting in NB heterogeneity in vitro. Therefore, de-differentiation of SH-IN cells by partial reprogramming may model the plasticity of tumor cells in NBs. Additionally, expression of CD133, ALDH1A1, ARID3B, and NCYM -but not MYCN-was induced in SH-IN 4F cells. Previous reports suggest that the expression level of MYCN is not associated with poor prognosis in MYCN non-amplified NBs, while the level of NCYM is associated with poor prognosis. (32) Therefore, overexpression of reprogramming factors may contribute to chemoresistance in MYCN-non amplified SH-IN cells, possibly by induction of these stem-cell related genes. (29) (30) (31) (32) 35, 36) Our present findings indicate that partially reprogrammed NB cells could be a valuable in vitro model for understanding how NB cells maintain plasticity and aggressiveness. 
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